In patients with mild to moderate SLE, a single dose of AMG 811 was well tolerated and could normalize IFN-regulated gene expression, resulting in a dose-dependent decrease in serum CXCL-10 levels (14, 129). This evidence concerns the gene CXCL10 and systemic lupus erythematosus.